Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

PUBLICATION DATE

6 results
Display

Management and Evaluation Prior to Transplantation of Deceased Donor

Jung JH, Park SK, Lee S

The number of people awaiting organ transplantation continues to exceed the number of organs available for transplantation, especially at a time when kidney transplantation is recognized as the best treatment...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Squamous Cell Carcinoma in Nasal Cavity Treated with Conversion to Sirolimus in a Patient with Kidney Transplantation

Ryu TH, Choi SH, Jung P, Lee KH, Kim HS, Oh JS, Kim SM, Sin YH, Kim JK

Conversion of immunosuppressants to sirolimus, an inhibitor of mammalian target of rapamycin, is a useful treatment option for prevention of the adverse events of immunosuppressants such as calcineurin inhibitor in...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Research for Modification of Emergency Status in Deceased Donor Liver Allocation: Survival Analysis of Waiting Patients for Liver Transplantation

Kim MS, Lee KW, Hwang S, Kwon CH, You YK, Nah YW, Yu HC, Kim DS, Wang HJ, Choi DL, Choi IS, Kim SI

Despite a remarkable increase of deceased donors, organ shortage is the main hurdle of organ transplantation in Korea. Therefore, liver transplantation priority is a major issue of liver allocation. We...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Treatment of Refractory Antibody-mediated Rejection with Bortezomib in a Kidney Transplant Recipient: A Case Report

Lee JY, Yoo JY, Kwon SH, Jeon JS, Noh H, Han DC, Song D, Jin SY

Antibody-mediated rejection (ABMR) is associated with poor renal allograft survival. It shows poor response to conventional treatment with plasmapheresis, rituximab, and intravenous immunoglobulin. Bortezomib, a proteasome inhibitor used for treatment...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Actual 10-year Outcomes of Tacrolimus/MMF Compared with Cyclosporin/MMF in Kidney Transplantation

Kim Y, Park S, Kim H, Han S

BACKGROUND: Kidney transplantation is the most effective treatment in patients with chronic kidney disease. Recently, the survival rate of kidney allografts has been markedly increased by the development of immunosuppressants....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Validation of the KDRI in Korean Deceased Donor Kidney Transplantation

Park UJ, Kim MY, Kim HT, Cho WH

BACKGROUND: The United Network for Organ Sharing developed the continuous kidney donor risk index (KDRI) for measurement of the spectrum of risk associated with the various factors known to influence...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr